DR. MICHAEL A GEFFIN MD NPI 1578583902

NPI Details

DR. Michael A Geffin, MD is an urology in Plymouth, MA with 32 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Michael A Geffin, MD NPI is 1578583902. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BOSTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1994

The provider's business location address is:

51 OBERY ST
PLYMOUTH, MA
ZIP 02360-129
Phone: (978) 927-0714
Fax: (978) 927-9135

The NPI 1578583902 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Analysis for detection of tumor marker (HCPCS:86316)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Testosterone (hormone) level, total (HCPCS:84403)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• 3d radiographic procedure with computerized image postprocessing (HCPCS:76377)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Simple change of bladder tube (HCPCS:51705)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Complete laser vaporization of prostate including control of bleeding using an endoscope (HCPCS:52648)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Insertion of tube into ureter using an endoscope through bladder area (HCPCS:52005)
• Insertion of temporary bladder tube (HCPCS:51701)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Complicated insertion of bladder tube (HCPCS:51703)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Removal or manipulation of stone in ureter or kidney using an endoscope (HCPCS:52352)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 7/20/2006 and was last updated on 1/16/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.